Investigation of the [-/A]8 and C1236T genetic variations within the human toll-like receptor 3 gene for association with multiple sclerosis (with Attila L. Szvetko, Ashleigh Jones, Jason Mackenzie, Peter A. Csurhes, Judith M. Greer, Michael Pender, and Lyn Griffiths), Neurological research (2010)

An examination of MS candidate genes identified as differentially regulated in multiple sclerosis plaque tissue, using absolute and comparative real-time Q-PCR analysis (with A. S. Melllick, A. Tourtellotte, R. M. Nagra, and L. R. Griffiths), Brain research protocols (2005)

Variation in the vitamin D receptor gene is associated with multiple sclerosis in an Austrlaian population (with Micky Ovcaric, Rob Curtain, Matthew P. Johnson, Lyn R. Griffiths, Peter Csurhes, Michael P. Pender, and Rod A. Lea), Journal of neurogenetics (2005)

Investigation of the low-density lipoprotein receptor gene and cholesterol as a risk factor for migraine (with R. Curtain, R. A. Lea, S. Quinlan, C. Bellis, R. Hughes, J. MacMillan, and L. R. Griffiths), Journal of the neurological sciences (2004)

Investigation of an inducible nitric oxide synthase gene (NOS2A) polymorphism in a multiple sclerosis population (with Virginie Martin, Micky Ovcaric, Rob P. Curtain, Rod A. Lea, Peter Csurhes, Michael P. Pender, and Lyn R. Griffiths), Brain research bulletin (2004)

Investigation of a neuronal nitric oxide synthase gene (NOS1) polymorphism in a multiple sclerosis population (with Linda Ferreira, Micky Ovcaric, Rob Curtain, Rod Lea, Peter Csurhes, Michael P. Pender, and Lyn R. Griffiths), Journal of the neurological sciences (2004)

Quantitative and qualitative changes in gene expression patterns characterize the activity of plaques in multiple sclerosis (with Albert S. Mellick, Kevin J. Ashton, Anthony E. G. Tannenberg, Rashed M. Nagra, Wallace W. Tourtellotte, and Lyn R. Griffiths), Molecular brain research (2003)

No mutations detected in the INSR gene in a chromosome 19p13 linked migraine pedigree (with Robert Curtain, Rod Lea, John MacMillan, and Lyn Griffiths), European journal of medical genetics (2006)

Analysis of chromosome 1 microsatellite markers and the FHM2-ATP1A2 gene mutations in migraine pedigrees (with R. P. Curtain, R. A. Lea, L. H. Haupt, M. Ovcaric, J. MacMillan, and L. R. Griffiths), Neurological research (2005)

The methylentetrahydrofolate reductase gene variant (C677T) as a risk factor for essential hypertension in caucasians (with S. Heux, F. Morin, R. A. Lea, M. Ovcaric, and L. R. Griffiths), Hypertension research (2004)

The role of adenosine-related genes variants in susceptibility to essential hypertension (with Kirsty Wright, Rod A. Lea, Micky Ovcaric, Stephanie Heux, Fabien Morin, Wallid Bey, John P. Headrick, and Lyn R. Griffiths), Journal of hypertension (2004)

Adrenoceptor function and expression in bladder urothelium and lamina propria (with Christian Moro and Russ Chess-Williams), Urology (2012)

Link

Vasoactive neuropeptides in autoimmune diseases (with Ekua W. Brenu, Donald R. Staines, and Sonya M. Marshall-Gradisnik), Autoimmune disorders - Current concepts and advances from bedside to mechanistic insights (2011)

Link

Mechanism of autoimmunity in pregnancy - The good and the bad (with Ekua W. Brenu, Donald R. Staines, and Sonya M. Marshall-Gradisnik), Autoimmune disorders - Pathogenetic aspects (2011)

PDF

Assessment of immune function after short-term administration of recombinant human growth hormone in healthy young males (with Sandra B. Ramos, Ekua W. Brenu, Rhys Christy, A. Bon Gray, Lars McNaughton, Mieke Van Driel, and Sonya M. Marshall-Gradisnik), European journal of applied physiology (2011)

Immunomodulators as therapeutic strategies for managing Multiple Sclerosis (with Ekua W. Brenu, Donald R. Staines, and Sonya Marshall-Gradisnik), Autoimmune disorders: Symptoms, diagnosis and treatment (2011)

Study of leukemia inhibitory factor polymorphism within an Australian multiple sclerosis population (with Jason Mackenzie, Attila Szvetko, Verena Weth, Julie Moreau, Judith M. Greer, Peter A. Csurhes, Michael P. Pender, and Lyn R. Griffiths), Study of leukemia inhibitory factor polymorphism within an Australian multiple sclerosis population (2009)

An investigation of the C77G and C772T variations within the human protein tyrosine phosphatase receptor type C gene for association with multiple sclerosis in an Australian population (with Attila L. Szvetko, Ashleigh Jones, Jason Mackenzie, Peter A. Csurhes, Judith M. Greer, Michael P. Pender, and Lyn R. Griffiths), Brain research (2009)

Gene expression studies in multiple sclerosis (with Francesca Fernandez and Lyn R. Griffiths), Current genomics (2007)

Allelic variation investigation of the estrogen receptor within an australian multiple sclerosis population (with Francesca Fernandez, Sophie Tajouri, Geraldine Detriche, Attila Szvetko, Natalie Colson, Peter Csurhes, Michael P. Pender, and Lyn R. Griffiths), Journal of the neurological sciences (2007)

No association between MTHFR A1298C and MTRR A66G polymorphisms, and MS in an Australian cohort (with A. L. Szvetko, J. Fowdar, J. Nelson, N. Colson, P. A. Csurhes, M. P. Pender, and L. R. Griffiths), Journal of neurological sciences (2007)

Genetic investigation of methylenetetrahydrofolate reductase (MTHFR) and catechol-O-methyl transferase (COMT) in multiple sclerosis (with Virginie Martin, Claudia Gasparini, Micky Ovcaric, Rob Curtain, Rod A. Lea, Larisa M. Haupt, Peter Csurhes, Michael P. Pender, and Lyn R. Griffiths), Brain research bulletin (2006)